Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 3 filers reported holding Santen Pharmaceutical Co Ltd in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | -38.5% | 2,088 | -18.5% | 0.00% | – |
| Q1 2022 | $26,000 | -10.3% | 2,563 | +6.4% | 0.00% | – |
| Q4 2021 | $29,000 | +45.0% | 2,409 | +67.6% | 0.00% | – |
| Q3 2021 | $20,000 | +17.6% | 1,437 | +19.3% | 0.00% | – |
| Q2 2021 | $17,000 | +112.5% | 1,205 | +109.2% | 0.00% | – |
| Q1 2021 | $8,000 | – | 576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QUADRANT CAPITAL GROUP LLC | 15,237 | $245,000 | 0.04% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 1,176,056 | $19,393,000 | 0.02% |
| Private Capital Group, LLC | 189 | $3,000 | 0.00% |
| WealthStone, Inc. | 64 | $1,055,000 | 0.00% |
| GLENMEDE TRUST CO NA | 2,609 | $43,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 427 | $7,000 | 0.00% |